CAS: 587-54-2; 3-Benzamidobenzoic Acid

该化合物是一种芳香化合物,其特点是有碳酸和氨化物功能组,其特点是一种苯并因苯并基氨基组的元位置而与碳酸相对,以苯并基氨基组的代谢.该化合物一般是白色的脱白晶状固体,在水中溶解,但更易溶于乙醇和丙酮等有机溶剂,分子结构有助于其在制药中的潜在应用,特别是在染料合成和有机合成中作为中间体.矿和氨酸的功能都允许各种化学反应,包括串联和恐吓.此外,3-(苯并基氨基)苯甲酸可能会表现出生物活动,从而引起对药用化学的兴趣.适当的处理和储存由于其潜在的再活动性以及需要与化学物质合作时的安全防范,至关重要.

结构式图片

上下游产品

pyridine benzoyl chloride meta-aminobenzoic acid N-phenyl benzoyl amide 5-benzoylamino-2-amino-benzoic acid 3-(benzoylamino)-N-phenylbenzamide 3-(benzoylamino)benzoic acid chloride 3-(N-benzoyl-N-methylamino)benzoic acid

合成工艺路线路线简述

    📜3-Benzoylamino-Benzoic Acid Methyl Ester置于水,Sodium Hydroxide体系中,用 甲醇 作为反应溶剂,化学反应 2.0H,反应生成 5,7-二甲基吡唑并嘧啶-2-羧酸
    参考文献:Structure-Based Design And Synthesis Of Novel Inhibitors Targeting Hdac8 From Schistosoma Mansoni For The Treatment Of Schistosomiasis
    标题:Structure-Based Design And Synthesis Of Novel Inhibitors Targeting Hdac8 From Schistosoma Mansoni For The Treatment Of Schistosomiasis
    摘要:Schistosomiasis Is A Major Neglected Parasitic Disease That Affects More Than 265 Million People Worldwide And For Which The Control Strategy Consists Of Mass Treatment With The Only Available Drug,Praziquantel. In This Study,A Series Of New Benzohydroxamates Were Prepared As Potent Inhibitors Of Schistosoma Mansoni Histone Deacetylase 8 (Smhdac8). Crystallographic Analysis Provided Insights Into The: Inhibition Mode Of Smhdac8 Activity By These 3-Amidobenzohydroxamates. The Newly Designed Inhibitors Were Evaluated In Screens For Enzyme Inhibitory Activity Against Schistosome And Human Hdacs. Twenty-Seven Compounds Were Found To Be Active In The Nanomolar Range,And Some Of Them Showed Selectivity Toward Smhdac8 Over The Major Human Hdacs (I And 6). The Active Benzohydroxamates Were Additionally Screened For Lethality Against The Schistosome Larval Stage Using A Fluorescence-Based Assay. Four Of These Showed Significant Dose-Dependent Killing Of The Schistosome Larvae And Markedly Impaired Egg Laying Of Adult Worm Pairs Maintained In Culture.
    DOI:10.1021/acs.Jmedchem.5B01478

    海关参考信息

    专利信息


    专利号:RU-2170737-C2
    优先权日:1994-07-11
    标 题:Heterobicyclic derivatives, methods of their synthesis and pharmaceutical composition

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s13361-011-0164-2
    摘要:Attygalle AB, Nishshanka U, Weisbecker CS. “Meta Elimination,” a Diagnostic Fragmentation in Mass Spectrometry. Journal of The American Society for Mass Spectrometry. 2011 Jun 03;22(9):1515–25. doi: 10.1007/s13361-011-0164-2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知